FerriScan is being used by clinicians in over 30 countries worldwide to aid their diagnosis, management and monitoring of iron overload.
FerriScan is a solution with proven value in improving the health outcomes of patients suffering from diseases such as thalassaemia, sickle cell disease, haemochromatosis and myelodysplastic syndrome.
Frequently Asked Questions
Case Studies
A number of case studies referencing FerriScan have been published by centres of excellence:
Use of FerriScan in Disease Management
FerriScan provides the clinician with:
- A baseline measurement of the precise concentration and distribution of iron in the liver
- Assistance in providing a definitive iron overload diagnosis
- The ability to optimise treatment based on the level of iron loading; thereby enabling positive treatment outcomes
Use of FerriScan in Iron Overload Management Protocols
- Iron Overload Assessment and Monitoring Protocol
- Myelodysplastic Syndrome Protocol
- Paediatric Thalassaemia Disorders
Iron Overload Information and Evidence of FerriScan Use (Presentations)
Scientific Evidence in Iron Overload Measurement
Resonance Health has developed a reputation for the highest standards of scientific rigour, which is underpinned by our company-wide commitment to quality and continuous improvement.
FerriScan has been validated by international regulatory authorities and is widely used by major pharmaceutical companies in clinical trial settings.
A number of scientific publications have provided evidence for the use of FerriScan in clinical management of iron overload conditions.
- FerriScan Scientific Publications List
- Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
- Why Use FerriScan® R2-MRI to Measure Liver Iron Concentration?
FerriScan: Patient Management Guidelines
An increasing number of patient treatment guidelines for thalassaemia, sickle cell disease, myelodysplastic syndrome and haemochromatosis recommend using MRI to quantitatively measure liver iron concentration.
For a compiled list of treatment guidelines involving R2 MRI (FerriScan), please click here.